Alaya.bio
PrivateLast Round
Series A
Jul 10, 2026
Total Funding Raised
$9.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alaya.bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in December 2022.
Alaya.bio is a biotechnology company developing a proprietary polymeric nanoparticle platform for in-vivo CAR-T cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alaya.bio Comparables
Compare Alaya.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera Therapeutics | 86% | |
| ACIRNA Therapeutics | 84% | |
| Abintus Bio | 82% |
For institutional investors. Book with your work email.
Alaya.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 10, 2026 | ||||
| Seed | Dec 1, 2022 | ||||
| Pre Seed | Aug 8, 2022 |
For institutional investors. Book with your work email.
Alaya.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Seed |
| Mission BioCapital | Pre Seed |
| Volnay Therapeutics | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2026
Raised $10.9M pre-money valuation.
- Aug 8, 2022
$3M round led by Mission BioCapital and Volnay Therapeutics.
For institutional investors. Book with your work email.
Alaya.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alaya.bio's valuation, stock price, and market status.
Is Alaya.bio a public or private company?
Alaya.bio is a private company.
What is the current stock price of Alaya.bio?
Alaya.bio is a private company, so its shares have no public market price. Caplight tracks Alaya.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alaya.bio worth (valuation)?
Valuation information for Alaya.bio is not publicly available.
Can I buy Alaya.bio stock?
Alaya.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alaya.bio's last funding round?
Alaya.bio's most recent funding round was Series A on July 10, 2026.
Who are the main investors in Alaya.bio?
Key investors in Alaya.bio include Volnay Therapeutics.
Will Alaya.bio IPO soon?
No public IPO plans have been announced for Alaya.bio.
How can I track Alaya.bio secondary market activity?
Caplight tracks bids, offers, and trades in Alaya.bio's shares on secondary markets.